Julian Peto

Q: What Schools Are Affiliated With Julian Peto

Julian Peto is affiliated with the following schools: Institute of Cancer Research, Imperial College London, University of New Mexico, Queen Mary University of London, London School of Hygiene and Tropical Medicine, Technical University of Munich, Karolinska Institute, Leiden University, University of Southampton

Julian Peto's AcademicInfluence.com Rankings

Julian Peto

Mathematics

#3066

World Rank

#4602

Historical Rank

Statistics

#132

World Rank

#173

Historical Rank

mathematics Degrees

Download Badge

Mathematics

Why Is Julian Peto Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Julian Peto is an English statistician and cancer epidemiologist at the London School of Hygiene and Tropical Medicine. He was Cancer Research UK Chair of Epidemiology at the Institute of Cancer Research from 1983 until 2010. From 1974 to 1983 he worked as a research scientist under Sir Richard Doll at the University of Oxford.

(See a Problem?)

Julian Peto's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide (1999) (8614)
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. (1977) (8359)
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. (2003) (3543)
Asymptotically Efficient Rank Invariant Test Procedures (1972) (3318)
Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective (1995) (3227)
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. (1998) (2846)
Identification of the breast cancer susceptibility gene BRCA2 (1995) (2451)
Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer (1997) (2362)
Genome-wide association study identifies novel breast cancer susceptibility loci (2007) (2351)
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. (1976) (2066)
Identification of the breast cancer susceptibility gene BRCA2 (1996) (1451)
Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. (1995) (1300)
Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials (2014) (1236)
Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies (1996) (1205)
Large-scale genotyping identifies 41 new loci associated with breast cancer risk (2013) (1063)
Association analysis identifies 65 new breast cancer risk loci (2017) (922)
The European mesothelioma epidemic (1999) (912)
Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. (1999) (876)
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis (2012) (864)
Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations (2002) (860)
A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21 (2007) (838)
The cervical cancer epidemic that screening has prevented in the UK (2004) (802)
Alcohol, tobacco and breast cancer – collaborative reanalysis of individual data from 53 epidemiological studies, including 58 515 women with breast cancer and 95 067 women without the disease (2002) (781)
Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies (2012) (745)
Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. (2012) (733)
Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. (1998) (700)
Cancer epidemiology in the last century and the next decade (2001) (671)
Prediction of BRCA1 Status in Patients with Breast Cancer Using Estrogen Receptor and Basal Phenotype (2005) (667)
Guidelines for simple, sensitive significance tests for carcinogenic effects in long-term animal experiments. (1980) (612)
Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study (2011) (602)
Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. (1979) (586)
A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3 (2008) (578)
Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. (1995) (576)
Continuing increase in mesothelioma mortality in Britain (1995) (574)
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes (2018) (559)
MicroRNA Related Polymorphisms and Breast Cancer Risk (2014) (557)
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer (2013) (534)
A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk (2007) (528)
A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes (2002) (528)
Parent-of-origin specific allelic associations among 106 genomic loci for age at menarche (2014) (511)
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2 (2009) (502)
Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer (2015) (502)
Cervical cancer and use of hormonal contraceptives: a systematic review (2003) (471)
Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants (2015) (471)
Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16 573 women with cervical cancer and 35 509 women without cervical cancer from 24 epidemiological studies (2007) (462)
CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies. (2004) (442)
Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective (1997) (426)
Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. (1991) (415)
Genome-wide association studies identify four ER negative–specific breast cancer risk loci (2013) (411)
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions (2008) (403)
Carcinoma of the cervix and tobacco smoking: Collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies (2006) (395)
IARC monographs programme on the evaluation of carcinogenic risks to humans (2007) (393)
HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial. (2009) (388)
RAD51B in Familial Breast Cancer (2016) (366)
Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk (2017) (359)
A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population (2010) (357)
The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050 (2005) (354)
Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence (2019) (350)
The Classification of Smoking by Factorial Structure of Motives (1974) (344)
Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer risk (2008) (320)
Large-scale genomic analyses link reproductive ageing to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair (2015) (308)
A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor–negative breast cancer (2011) (306)
High constant incidence in twins and other relatives of women with breast cancer (2000) (297)
Genome-wide association analysis identifies three new breast cancer susceptibility loci (2012) (291)
Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case–control study nested within the Manchester cohort (2000) (286)
Immunologically Defined Subclasses of Acute Lymphoblastic Leukaemia in Children: their Relationship to Presentation Features and Prognosis (1981) (279)
PROSPECTIVE STUDY OF CANCER IN PATIENTS WITH HYPOGAMMAGLOBULINAEMIA (1985) (279)
Cohort study analysis with a FORTRAN computer program. (1986) (274)
Lifetime risks of common cancers among retinoblastoma survivors. (2004) (271)
Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study. (2011) (263)
Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: Systematic overview of 10 case‐control studies (1995) (255)
Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort (2004) (250)
Mesothelioma mortality in asbestos workers: implications for models of carcinogenesis and risk assessment. (1982) (247)
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer (2017) (244)
The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2. (2000) (239)
Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. (2013) (225)
Occupational, domestic and environmental mesothelioma risks in the British population: a case–control study (2009) (222)
The search for low-penetrance cancer susceptibility alleles (2004) (219)
HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial (2006) (216)
ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening. (2009) (210)
An overview of prognostic factors in small cell lung cancer. A report from the Subcommittee for the Management of Lung Cancer of the United Kingdom Coordinating Committee on Cancer Research. (1990) (210)
p53 mutation with frequent novel codons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours (1998) (196)
Risk of cutaneous melanoma associated with a family history of the disease (1995) (196)
Relationship of mortality to measures of environmental asbestos pollution in an asbestos textile factory. (1985) (182)
A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. (2012) (182)
Duration and intensity of maintenance chemotherapy in acute lymphoblastic leukaemia: overview of 42 trials involving 12 000 randomised children (1996) (177)
A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: extended follow up in the ARTISTIC trial. (2011) (175)
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS (2016) (174)
Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q (1994) (173)
Covid-19 mass testing facilities could end the epidemic rapidly (2020) (164)
Inherited susceptibility to breast cancer. (1993) (159)
Evidence of Gene–Environment Interactions between Common Breast Cancer Susceptibility Loci and Established Environmental Risk Factors (2013) (159)
Breast cancer and hormonal contraceptives: further results (1996) (158)
Cancer survival is dependent on season of diagnosis and sunlight exposure (2006) (154)
Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers. (2016) (154)
Risk factors for adenocarcinoma and squamous cell carcinoma of the cervix in women aged 20–44 years: the UK National Case–Control Study of Cervical Cancer (2003) (150)
Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies (2005) (149)
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer (2018) (149)
Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14 (2013) (149)
Day care in infancy and risk of childhood acute lymphoblastic leukaemia: findings from UK case-control study (2005) (146)
Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types. (2016) (146)
MVPP chemotherapy regimen for advanced Hodgkin's disease (1978) (145)
Polymorphisms and circulating levels in the insulin-like growth factor system and risk of breast cancer: a systematic review. (2005) (144)
Time since first sexual intercourse and the risk of cervical cancer (2012) (142)
Cancers of the respiratory tract in mustard gas workers. (1988) (139)
Common BRCA1 variants and susceptibility to breast and ovarian cancer in the general population. (1997) (136)
Intratype variation in 12 human papillomavirus types: a worldwide perspective (1996) (134)
Gene-body hypermethylation of ATM in peripheral blood DNA of bilateral breast cancer patients (2009) (133)
The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds. (2014) (133)
Association analyses identify 31 new risk loci for colorectal cancer susceptibility (2019) (132)
Cancer mortality in relatives of women with ovarian cancer: The OPCS study (1996) (132)
Comprehensive analysis of the contribution of germline MYH variation to early‐onset colorectal cancer (2004) (130)
Universal weekly testing as the UK COVID-19 lockdown exit strategy (2020) (127)
National Screening Committee’s criteria for appraising the viability, effectiveness and appropriateness of a screening programme (2014) (125)
Common breast cancer susceptibility loci are associated with triple-negative breast cancer. (2011) (124)
Genetics and the common cancers. (2001) (123)
Cancer mortality in relatives of women with breast cancer: The OPCS study (1996) (122)
Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170 (2016) (122)
Identification of nine new susceptibility loci for endometrial cancer (2018) (122)
Counting potentially functional variants in BRCA1, BRCA2 and ATM predicts breast cancer susceptibility. (2007) (121)
Identification of a BRCA2-Specific Modifier Locus at 6p24 Related to Breast Cancer Risk (2013) (120)
The contribution of inherited predisposition to cancer incidence. (1990) (120)
Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (Report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood) (1991) (119)
Consensus Report of the 2015 Weinman International Conference on Mesothelioma (2016) (117)
The future of association studies of common cancers (2003) (117)
A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein-3 and breast cancer risk (2005) (117)
Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. (2009) (116)
19p13.1 is a triple-negative-specific breast cancer susceptibility locus. (2012) (115)
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions (2008) (112)
Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation (2014) (112)
Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial (2008) (111)
HIGH RATE OF HUMAN PAPILLOMAVIRUS TYPE 16 INFECTION IN CYTOLOGICALLY NORMAL CERVICES (1989) (110)
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses (2019) (110)
Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. (2013) (109)
Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization. (2015) (107)
Cervical Carcinoma and Sexual Behavior: Collaborative Reanalysis of Individual Data on 15,461 Women with Cervical Carcinoma and 29,164 Women without Cervical Carcinoma from 21 Epidemiological Studies (2009) (107)
Lack of evidence on diets for obesity for children: a systematic review. (2006) (107)
Identification of 19 new risk loci and potential regulatory mechanisms influencing susceptibility to testicular germ cell tumor (2017) (104)
Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia (2014) (103)
Prevalence of BRCA 1 and BRCA 2 Gene Mutations in Patients With Early-Onset Breast Cancer (1999) (100)
Association of ESR1 gene tagging SNPs with breast cancer risk. (2009) (95)
Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer (2016) (95)
National study of colorectal cancer genetics (2007) (92)
Current CD4 cell count and the short-term risk of AIDS and death before the availability of effective antiretroviral therapy in HIV-infected children and adults. (2008) (91)
Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. (2011) (90)
Non-occupational exposure to mineral fibres (1989) (89)
The Mesothelioma and Radical Surgery Randomized Controlled Trial: The MARS Feasibility Study (2009) (89)
Estimating the asbestos-related lung cancer burden from mesothelioma mortality (2012) (88)
That the effects of smoking should be measured in pack-years: misconceptions 4 (2012) (87)
Do MDM2 SNP309 and TP53 R72P interact in breast cancer susceptibility? A large pooled series from the breast cancer association consortium. (2007) (87)
Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations. (2016) (87)
Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. (2015) (86)
Ovarian ablation or suppression in premenopausal early breast cancer: results from the international adjuvant breast cancer ovarian ablation or suppression randomized trial. (2007) (85)
Interaction between CHEK2*1100delC and other low-penetrance breast-cancer susceptibility genes: a familial study (2005) (85)
Pleural mesothelioma and lung cancer risks in relation to occupational history and asbestos lung burden (2015) (83)
Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma (2018) (81)
Completeness of cancer registration: a new method for routine use (2000) (81)
Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis. (2018) (80)
A Genome-wide Association Study of Early-Onset Breast Cancer Identifies PFKM as a Novel Breast Cancer Gene and Supports a Common Genetic Spectrum for Breast Cancer at Any Age (2014) (77)
Data protection, informed consent, and research (2004) (75)
Erratum to: “Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer” [Vaccine 30S5 (2012) F88–F99] (2013) (75)
Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms. (2016) (75)
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes (2019) (74)
Refinement of the basis and impact of common 11q23.1 variation to the risk of developing colorectal cancer. (2008) (73)
Eurogin 2010 roadmap on cervical cancer prevention (2011) (72)
Antibodies to human papillomavirus and to other genital infectious agents and invasive cervical cancer risk (1993) (69)
Uncommon CHEK2 mis-sense variant and reduced risk of tobacco-related cancers: case control study. (2007) (69)
Five Polymorphisms and Breast Cancer Risk: Results from the Breast Cancer Association Consortium (2009) (69)
Search for low penetrance alleles for colorectal cancer through a scan of 1467 non-synonymous SNPs in 2575 cases and 2707 controls with validation by kin-cohort analysis of 14 704 first-degree relatives. (2006) (68)
Genetic modifiers of CHEK2*1100delC associated breast cancer risk (2016) (68)
BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer. (2017) (67)
Premenopausal mammographic density in relation to cyclic variations in endogenous sex hormone levels, prolactin, and insulin-like growth factors. (2009) (66)
Low frequency of germline E-cadherin mutations in familial and nonfamilial gastric cancer (1999) (66)
THE HYGIENE STANDARD FOR CHRYSOTILE ASBESTOS (1978) (65)
Radical surgery for mesothelioma (2004) (65)
ORAL CONTRACEPTIVES AND CANCER (1983) (64)
Five endometrial cancer risk loci identified through genome-wide association analysis (2016) (64)
Association of Genetic Variants at 8q24 with Breast Cancer Risk (2008) (63)
Inconsistent association between the STK15 F31I genetic polymorphism and breast cancer risk. (2006) (63)
Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium (2014) (62)
Predicted anti-oestrogen resistance in BRCA-associated familial breast cancers. (1998) (60)
Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) (2012) (60)
Optimal Threshold for a Positive Hybrid Capture 2 Test for Detection of Human Papillomavirus: Data from the ARTISTIC Trial (2009) (59)
Persisting risk of nickel related lung cancer and nasal cancer among Clydach refiners (2006) (57)
Hormone status of in-situ cancer in BRCA1 and BRCA2 mutation carriers (1998) (57)
Family History, Genetic Testing, and Clinical Risk Prediction: Pooled Analysis of CHEK2*1100delC in 1,828 Bilateral Breast Cancers and 7,030 Controls (2009) (57)
Cancer in patients treated with immunosuppressive drugs. (1981) (56)
Genetic overlap between endometriosis and endometrial cancer: evidence from cross‐disease genetic correlation and GWAS meta‐analyses (2018) (56)
Body fatness and physical activity at young ages and the risk of breast cancer in premenopausal women (2005) (56)
Breast cancer susceptibility-A new look at an old model. (2002) (56)
The Insulin-Like Growth Factor System and Mammographic Features in Premenopausal and Postmenopausal Women (2006) (56)
Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer (2016) (54)
HIV TESTING ON ALL PREGNANT WOMEN (1987) (52)
Association of a common AKAP9 variant with breast cancer risk: a collaborative analysis. (2008) (52)
Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk. (2015) (51)
TREATMENT OF INOPERABLE CARCINOMA OF BRONCHUS (1975) (51)
Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia (2018) (50)
Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2 (2015) (50)
Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast (2014) (49)
Prevalence of the APC E1317Q variant in colorectal cancer patients. (2000) (49)
Contribution of environmental fibers to respiratory cancer. (1986) (49)
A mortality study among workers in an English asbestos factory. (1977) (48)
Identification of genetic variants that influence circulating IGF1 levels: a targeted search strategy. (2008) (48)
Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk (2014) (47)
Drinking in a London suburb. II. Correlates of trouble with drinking among men. (1972) (47)
Genetic predisposition to ductal carcinoma in situ of the breast (2016) (46)
Oral contraceptive use and breast cancer risk in young women. (1989) (43)
A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium. (2014) (40)
Models for respiratory cancer in nickel refinery workers. (1986) (40)
Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression. (2015) (39)
A comparison of female and male motivation for drinking. (1973) (38)
11q13 is a susceptibility locus for hormone receptor positive breast cancer (2012) (38)
Missense Variants in ATM in 26,101 Breast Cancer Cases and 29,842 Controls (2010) (38)
Bladder cancer mortality of workers exposed to aromatic amines: analysis of models of carcinogenesis. (1985) (38)
Genetic heterogeneity and localization of a familial breast-ovarian cancer gene on chromosome 17q12-q21. (1993) (37)
A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6 q 14 and 20 q 11 (2012) (36)
Efficacy of HPV-based screening for prevention of invasive cervical cancer : Follow-up of four European randomized controlled trials (2014) (35)
Bladder cancer mortality of workers exposed to aromatic amines: an updated analysis. (1991) (35)
Oral contraceptive use and breast cancer risk in young women: subgroup analyses (1990) (35)
An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression. (2016) (35)
An age, period and cohort analysis of pleural cancer mortality in Europe. (2000) (34)
TREATMENT OF INOPERABLE CARCINOMA OF BRONCHUS (1976) (34)
Motivation for drinking among men: survey of a London suburb (1972) (34)
Candidate locus analysis of the TERT–CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk (2014) (34)
Confirmation of 5p12 As a Susceptibility Locus for Progesterone-Receptor–Positive, Lower Grade Breast Cancer (2011) (33)
Identification of New Genetic Susceptibility Loci for Breast Cancer Through Consideration of Gene‐Environment Interactions (2014) (33)
Lung cancer mortality in relation to measured dust levels in an asbestos textile factory. (1980) (33)
Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21 (2016) (33)
An update of cancer mortality among chrysotile asbestos miners in Balangero, northern Italy. (1990) (32)
Respiratory cancer mortality in welsh nickel refiners : which nickel compounds are responsible? (1992) (32)
Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1 (2015) (32)
Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility (2017) (32)
Weekly COVID-19 testing with household quarantine and contact tracing is feasible and would probably end the epidemic (2020) (32)
Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus (2016) (32)
Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study (2014) (31)
Respiratory cancer mortality of Welsh nickel refinery workers. (1984) (31)
CYP3A variation, premenopausal estrone levels, and breast cancer risk. (2012) (31)
Multi-stage genome-wide association study identifies new susceptibility locus for testicular germ cell tumour on chromosome 3q25. (2015) (31)
DOSE‐RESPONSE RELATIONSHIPS FOR ASBESTOS‐RELATED DISEASE: IMPLICATIONS FOR HYGIENE STANDARDS PART II. MORTALITY (1979) (31)
Active and passive smoking and the risk of breast cancer in women aged 36–45 years: a population based case–control study in the UK (2007) (30)
The role of radiotherapy in treatment of inoperable lung cancer. (1977) (28)
Cytochrome P450 Allele CYP3A7*1C Associates with Adverse Outcomes in Chronic Lymphocytic Leukemia, Breast, and Lung Cancer. (2016) (27)
HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT. (2019) (27)
Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk. (2020) (27)
Fibre carcinogenesis and environmental hazards. (1989) (24)
Absence of linkage to the ataxia telangiectasia locus in familial breast cancer (1993) (24)
9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium (2012) (24)
Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma. (2019) (23)
Association of ESR 1 gene tagging SNPs with breast cancer risk (2009) (23)
Drinking in a London suburb. Reinterview of a subsample and assessment of response consistency. (1973) (23)
Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer. (2015) (23)
Past and current asbestos exposure and future mesothelioma risks in Britain: The Inhaled Particles Study (TIPS) (2018) (23)
FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium (2014) (22)
Breast cancer risk variants at 6 q 25 display different phenotype associations and regulate ESR 1 , RMND 1 and CCDC 170 (2016) (22)
Drinking problems among recidivist prisoners (1971) (22)
ESR1 gene amplification in breast cancer: a common phenomenon? (2008) (22)
Drinking in a London suburb. 3. Comparisons of drinking troubles among men and women. (1972) (22)
AIDS AND PROMISCUITY (1986) (22)
The Biology of Cancer—A New Approach (1977) (21)
Occupational, domestic and environmental mesothelioma risks in Britain (2009) (20)
Cancer mortality in the first degree relatives of young breast cancer patients. (1992) (20)
Sexual behavior and HPV infection in British women, by postal questionnaires and telephone interviews (2011) (20)
The incidence of pleural mesothelioma in chrysotile asbestos textile workers. (1980) (20)
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer (2019) (20)
Cancer treatment trials--past failures, current progress and future prospects. (1989) (19)
Radon and the risks of cancer (1990) (19)
Large-scale Analysis Demonstrates Familial Testicular Cancer to have Polygenic Aetiology. (2018) (18)
ORAL CONTRACEPTIVES AND BREAST CANCER: IS THE CASH STUDY REALLY NEGATIVE? (1989) (18)
The BRCA2 c.68‐7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity (2018) (18)
A genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replication (2013) (18)
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. (2016) (18)
Modelling the Health and Economic Impacts of Population-Wide Testing, Contact Tracing and Isolation (PTTI) Strategies for COVID-19 in the UK (2020) (17)
Certified causes of death in patients with mesothelioma in South East England (2009) (17)
ORAL CONTRACEPTIVES AND BREAST CANCER (1983) (17)
A novel human papillomavirus sequence from an international cervical cancer study. (1994) (16)
Mesothelioma mortality in Britain: Patterns by birth cohort and occupation (1997) (16)
Genome-wide association study implicates immune dysfunction in the development of Hodgkin lymphoma. (2018) (16)
Transcriptome-wide association study of breast cancer risk by estrogen-receptor status (2020) (16)
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (2021) (15)
Radon risk reassessed (1994) (15)
Genetic modifiers of CHEK 2 * 1100 delC-associated breast cancer risk (2017) (15)
Analysis of treatment of childhood leukaemia. V. Advantage of reduced chemotherapy during and immediately after cranial irradiation. (1977) (15)
Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade. (2014) (14)
Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer. (2015) (14)
Survival in surgically diagnosed patients with malignant mesothelioma in current practice (2002) (14)
That lung cancer incidence falls in ex-smokers: misconceptions 2 (2011) (14)
Breast Cancer Risk and 6q22.33: Combined Results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2 (2012) (14)
Early- and late-stage carcinogenesis in mouse skin and in man. (1984) (13)
Acute lymphoblastic leukaemia: four-year survivals old and new. (1981) (13)
Breast cancer onset in twins and women with bilateral disease. (2008) (13)
High-dose oral vitamin D supplementation and mortality in people aged 65-84 years: the VIDAL cluster feasibility RCT of open versus double-blind individual randomisation. (2020) (12)
CYP3A7*1C allele is associated with reduced levels of 2-hydroxylation pathway oestrogen metabolites (2017) (12)
Identification and characterization of novel associations in the CASP 8 / ALS 2 CR 12 region on chromosome 2 with breast cancer risk (2014) (11)
Medical Research Council Childhood Leukaemia Trial VIII compared with trials II-VII: lessons for future management. (1987) (11)
Fine-mapping of the HNF 1 B multicancer locus identi fi es candidate variants thatmediate endometrial cancer risk (2015) (11)
Oral contraceptives and cervical cancer (2002) (11)
Association of Genetic Variants at 8 q 24 with Breast Cancer Risk (2008) (11)
Triaging women with human papillomavirus infection and normal cytology or low‐grade dyskaryosis: evidence from 10‐year follow up of the ARTISTIC trial cohort (2019) (11)
COMBINATION TREATMENT IN ADVANCED HEAD AND NECK CANCER (1982) (10)
Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium (2015) (10)
Validation of loci at 2q14.2 and 15q21.3 as risk factors for testicular cancer (2017) (10)
Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche DTU Orbit (05/11/2017) (2014) (10)
Letter: Treatment of inoperable carcinoma of bronchus. (1976) (10)
PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1 (2017) (9)
Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes (2019) (9)
The PapilloCheck Assay for Detection of High-Grade Cervical Intraepithelial Neoplasia (2015) (9)
Problems in Dose Response and Risk Assessment : The Example of Asbestos (1985) (8)
Does chemotherapy have a role in the management of patients with advanced head and neck cancer? Early results from the UK Head and Neck (UKHAN) Trial (2001) (8)
Estimating Causal Effects of Genetic Risk Variants for Breast Cancer Using Marker Data from Bilateral and Familial Cases (2011) (7)
Re: "Presenting statistical uncertainty in trends and dose-response relations". (2000) (7)
Cervical cancer screening in older women (2021) (7)
Common breast cancer risk loci predispose to distinct tumor subtypes (2019) (6)
Common variants in breast cancer risk loci predispose to distinct tumor subtypes (2022) (6)
Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation (2018) (6)
Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element (2021) (6)
The MARS feasibility trial : Conclusions not supported by data - Authors' reply (2011) (6)
7q21-rs6964587 and breast cancer risk: an extended case–control study by the Breast Cancer Association Consortium (2011) (6)
No Breast Cancer Association for Transforming Growth Factor-β Pathway Colorectal Cancer Single Nucleotide Polymorphisms (2009) (6)
Combined estrogen-progestogen contraceptives (2007) (6)
Longer screening intervals are recommended following a negative HPV test in primary cervical screening (2017) (6)
Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk (2011) (6)
Meta-analysis of epidemiological studies of carcinogenesis. (1992) (5)
HPV-based screening for prevention of invasive cervical cancer – Authors' reply (2014) (5)
Unnecessary obstacles to COVID-19 mass testing (2020) (5)
CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers (2021) (5)
Re. The Association Between Childhood Leukemia and Population Mixing: An Artifact of Focusing on Clusters? (2019) (5)
Combined estrogen-progestogen menopausal therapy (2007) (5)
The genetic epidemiology of ovarian cancer (1995) (5)
Runs of homozygosity and testicular cancer risk (2019) (5)
Cervical Cancer Screening by Human Papillomavirus Testing Followed by Cytology Triage (2017) (4)
Author Correction: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma (2019) (4)
Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) (2012) (4)
British nuclear test veteran family trios for the study of genetic risk (2022) (4)
Candidate locus analysis of the TERT–CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk (2014) (4)
Weekly population testing could stop this pandemic and prevent the next (2021) (4)
STRESS AND CANCER SURVEYS (1986) (4)
CYP 3 A Variation , Premenopausal Estrone Levels , and Breast Cancer Risk (2012) (4)
Reply to comment on Peto et al. (2020): Weekly COVID-19 testing with household quarantine and contact tracing is feasible and would probably end the epidemic (2021) (4)
Harms and benefits of screening to prevent cervical cancer (2004) (4)
A Breast Cancer-Associated SNP Adjacent toESR1Correlates with Oestrogen Receptor-α (ERα) Level in Invasive Breast Tumours.: (2009) (4)
Lung cancer. Radon risk reassessed. (1994) (3)
No evidence of increased mutations in the germline of a group of British nuclear test veterans (2022) (3)
Oral contraceptives and cervical cancer [letter] (2002) (3)
Guidelines for the economic analysis (2014) (3)
FEASIBILITY PHASE OF THE MESOTHELIOMA AND RADICAL SURGERY (MARS) RANDOMISED CONTROLLED TRIAL COMPARING EXTRA-PLEURAL PNEUMONECTOMY (EPP) WITH NO EPP IN PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA (2011) (3)
Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk (2020) (3)
Adjuvant Razoxane in Resectable Colorectal Cancer (1980) (3)
Mendelian randomisation study of smoking exposure in relation to breast cancer risk (2021) (3)
59 The mesothelioma and radical surgery (MARS) trial update (2006) (3)
Mesothelioma and radical surgery trial (MARS): the feasibility study process (2009) (3)
Reply: Comment on ‘Estimating the asbestos-related lung cancer burden from mesothelioma mortality' (2013) (3)
Research and privacy (2001) (2)
The A-T gene does not make a major contribution to familial breast cancer (1993) (2)
Prof. Peto and Sir Richard Doll reply (1986) (2)
Investigating the genetic relationship between Alzheimer’s disease and cancer using GWAS summary statistics (2017) (2)
Two truncating variants in FANCC and breast cancer risk (2019) (2)
Estimating the asbestos-related lung cancer burden from mesothelioma mortality (2014) (2)
Genomic analyses for age at menarche identify 389 independent signals and indicate BMI-independent effects of puberty timing on cancer susceptibility (2016) (2)
rs2735383, located at a microRNA binding site in the 3’UTR of NBS1, is not associated with breast cancer risk (2016) (2)
53 Principal results of the feasibility phase of the Mesothelioma and Radical Surgery trial (MARS-feasibility) (2011) (2)
Early results from the UK Head and Neck (UKHAN) Trial: The role of chemotherapy in primary management of advanced head and neck cancer (2001) (2)
CNS RELAPSE IN CHILDHOOD LEUKAEMIA (1981) (2)
Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study (2022) (2)
Passive smoking. (1986) (2)
Epidemiology. Radon and the risks of cancer. (1990) (2)
Reflections on the importance of strict adherence to treatment protocols: acute lymphoblastic leukaemia in children in the 1970s in the US and the UK (2018) (1)
Authors' reply to letters from Egilman et al and Oliver et al (2016) (1)
Commentary: Frailty and cancer. (2015) (1)
Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study (2014) (1)
Identiﬁcation of four novel susceptibility loci for oestrogen receptor negative breast cancer (2016) (1)
Fine-mapping of the HNF1Bmulticancer locus identifies candidate variants thatmediate endometrial cancer risk (2015) (1)
Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium (2015) (1)
Effect of Nonionic Detergents on Amplification of Human Papillomavirus DNA with Consensus Primers MY09 and MY11 (1998) (1)
Reply: Misunderstandings in the misconception on the use of pack-years in analysis of smoking (2013) (1)
Epidemiology of Malignant Pleural Mesothelioma in Europe (2016) (1)
Polymorphisms, endogenous hormone levels and familial breast cancer risk in premenopausal women (2010) (1)
Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia (2018) (1)
Modelling the health and economic impacts of different testing and tracing strategies for COVID-19 in the UK (2020) (1)
Identification of nine new susceptibility loci for endometrial cancer (2018) (1)
27: Worldwide prevention of cervical cancer (2014) (1)
case-control study lymphoblastic leukaemia: findings from UK Day care in infancy and risk of childhood acute (2007) (1)
Genetic predisposition to ductal carcinoma in situ of the breast (2016) (1)
ORAL CONTRACEPTIVES, BREAST CANCER, AND LACTATION (1989) (1)
Reed Elsevier and the arms trade revisited (2007) (1)
ORGANIZATION AND ANALYSIS OF COMPARATIVE THERAPEUTIC ESSAIS INVOLVING EXTENSIVE SUPERVISION OF THE SICK (1979) (1)
Screening for Cervical Cancer (2012) (1)
Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma (2018) (1)
Author Correction: Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility (2019) (1)
Breast Cancer Risk and 6 q 22 . 33 : Combined Results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA 1 / 2 (2012) (1)
Cohabitation, infection and breast cancer risk (2020) (1)
The final results of the ARTISTIC trial: A randomised trial of HPV testing and primary cervical screening (2007) (1)
33 The mesothelioma epidemic: Occupational, environmental and spontaneous cases (2006) (0)
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer (2018) (0)
Null Results in Brief No Breast Cancer Association for Transforming Growth Factor- β Pathway Colorectal Cancer Single Nucleotide Polymorphisms (2009) (0)
Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (2021) (0)
PapilloCheck® human papillomavirus genotyping (2014) (0)
Model predictions of the ARTISTIC trial (2014) (0)
Association of rs12662670 with breast cancer in Asian ER (2012) (0)
Further analysis of the ARTISTIC trial – Author's reply (2009) (0)
AD51B in Familial Breast Cancer (2016) (0)
Stage 2 Genome-Wide Association Study of Candidate Low Penetrance Genes Implicated in Breast Cancer Risk (2009) (0)
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes (2020) (0)
Oral contraceptives and cervical cancer. (2002) (0)
Letter: Taxes, smoking and health. (1976) (0)
Screening behaviour of women in the ARTISTIC trial (2014) (0)
Models for Infectious Human Diseases: HPV and cervical cancer (1996) (0)
sense Variants in ATM in 26 , 101 Breast Cancer B & P es and 29 , 842 Controls (2010) (0)
The story of Michael, whose small sins in childhood eventually multiplied (A cautionary tale for young biologists) (1996) (0)
population based studies 6174delT mutations: a combined analysis of 22 BRCA1 5382insC and 185delAG and BRCA2 Breast and ovarian cancer risks to carriers of the (2006) (0)
COX-2 inhibitors and risk of heart failure (2005) (0)
Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia | NOVA. The University of Newcastle's Digital Repository (2014) (0)
Cancer Using Marker Data from Bilateral and Familial Cases Estimating Causal Effects of Genetic Risk Variants for Breast (2012) (0)
Determining the test probability matrices for liquid-based cytology in ARTISTIC (2014) (0)
Author Correction: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma (2019) (0)
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses (2020) (0)
Patient information sheet: Manchester, Salford, Trafford and Ashton, Leigh & Wigan primary care trusts (2014) (0)
Cross-cancer genome-wide association analysis of lung, ovary, breast, prostate and colon cancer identifies a novel cancer locus at 1q22 (2015) (0)
Author Correction: Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia (2019) (0)
Past and future tobacco mortality (2001) (0)
rs 2735383 , located at a microRNA binding site in the 3 ’ UTR of NBS 1 , is not associated with breast cancer risk (2016) (0)
Effects on asbestos l health of exposure to (2007) (0)
Genetic variation in the immunosuppression pathway genes and breast cancer: a pooled analysis of 42,510 cases and 40,577 controls from the Breast (2015) (0)
Long-term risks of invasive cervical cancer following HPV infection: follow-up of two screening cohorts in Manchester (2023) (0)
Authors and Disclosures (2010) (0)
Molecular and Cellular Pathobiology 19 p 13 . 1 Is a Triple-Negative – Speci fi c Breast Cancer Susceptibility Locus (2012) (0)
Standard checklist for reporting studies of diagnostic accuracy (2014) (0)
Abstract P3-08-04: Impact of CYP3A variation on estrone levels and breast cancer risk (2012) (0)
Oral contraceptives and cervical cancer. Authors' reply (2002) (0)
TABLE 82, [Modelled inadequate rate of HPV test]. (2014) (0)
Epidemiology and Cancer (2010) (0)
GENOME-WIDE ASSOCIATION STUDY OF HODGKIN LYMPHOMA IDENTIFIES HISTOLOGY-SPECIFIC ASSOCIATIONS AND TRANSCRIPTIONAL REGULATORS OF DISEASE SUSCEPTIBILITY (2017) (0)
Collaborative UnitedKingdom- Australasian study ofcancer inpatients treated withimmunosuppressive drugs* (1979) (0)
132 The mesothelioma epidemic and the hidden asbestos-related lung cancer epidemic (2006) (0)
Vitamin D and Longevity (VIDAL) Trial: feasibility study of 1615 men and women aged 65-84 with cluster randomisation of 20 GP practices to open or double blind individual randomisation (2018) (0)
Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry (2023) (0)
CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers (2021) (0)
Definitions and statistical methods (2019) (0)
Further analysis of the ARTISTIC trial Reply (2009) (0)
Abstract P3-12-02: Polymorphisms, Endogenous Hormone Levels and Breast Cancer Risk in Premenopausal Women (2010) (0)
Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia (2014) (0)
P2-241 Evaluation of the national cervical screening programme in Chile (2011) (0)
Prospects for Rapid Worldwide Reduction of Cervical Cancer (2011) (0)
Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility (2017) (0)
The Biology of Cancer—A new Approach (1976) (0)
Covid-19 mass testing: throwing the baby out with the bathwater? (2020) (0)
Reply to “Risk for familial breast cancer increases with age” (2002) (0)
TAXES, SMOKING, AND HEALTH (1976) (0)
Key tables reproduced using the second definition of round 3 (2014) (0)
SS-31 CERVICAL CANCER CONTROL IN CHILE: THE NATIONAL CYTOLOGY LABORATORY NETWORK (2007) (0)
the Breast Cancer Association Consortium Five Polymorphisms and Breast Cancer Risk : Results from Updated (2009) (0)
Compliance with screening and management recommendations (2014) (0)
Author Correction: Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility (2019) (0)
Troubles with Drinking Questionnaire (2018) (0)
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer (2019) (0)
Type-specific cumulative incidence supplementary tables (2014) (0)
The MARS (mesothelioma and radical surgery) trial (2004) (0)
Breast feeding and riskof breast cancer in young women (1994) (0)
Sexual behaviour data for the population model (2014) (0)
Smoking Motivation Scale (2019) (0)
Screening and diagnostic test characteristics (2014) (0)
Fine-mapping identifies two additional susceptibility 9q31.2. (2015) (0)
Author Correction: Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia (2019) (0)
Risk for familial breast cancer increases with age - Reply (2002) (0)
Patient information sheet: Stockport primary care trust (2014) (0)
a novel candidate breast cancer susceptibility locus on (2017) (0)
Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus (2016) (0)
HPV-based screening for prevention of invasive cervical cancer Reply (2014) (0)
Propaganda wars (1982) (0)
UKHAN1: A prospective multi-centre randomised trial investigating chemotherapy as part of initial management in advanced head and neck cancer (2001) (0)
Summary Minutes of the U.S. Environmental Protection Agency (EPA) Science Advisory Board (SAB) Asbestos Committee Public Meeting of July 21-22, 2008 Committee Members: See Roster (Attachment A) (2008) (0)
J. Peto replies (1977) (0)
Oral contraceptives and cervical cancer [1] (multiple letters) (2002) (0)
Quality-adjusted life-year weights (2014) (0)
Association analyses identify 31 new risk loci for colorectal cancer susceptibility (2019) (0)
SNP rs2180341 per-allele hazard ratios (HRs) and 95% confidence intervals (CIs) among Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) in A. BRCA1 mutation carriers B. BRCA2 mutation carriers. (2012) (0)
Common variants in breast cancer risk loci predispose to distinct tumor subtypes (2022) (0)
Letters to the Editor (0)

This paper list is powered by the following services:

Other Resources About Julian Peto

en.wikipedia.org

What Schools Are Affiliated With Julian Peto?

Julian Peto is affiliated with the following schools: